About 2,200 results
Open links in new tab
Targeted Oncology - Immunotherapy, Biomarkers, and Cancer …
Neoadjuvant/Adjuvant Durvalumab Scores FDA Approval in …
Adjuvant T-DM1 Continues to Outperform Trastuzumab in HER2 …
FDA Accepts Cabozantinib Application in Advanced …
The Potential of STING Agonists Is Explored in Cancer
Addition of Pembro to Neoadjuvant Chemo Aids EFS in High-Risk …
Dostarlimab Plus SOC Chemo Meets Primary End Point in …
Recent Approvals Signal a Bright Future for Myelodysplastic …
High-Dose Radiation Plus Long-Term ADT Improves Survival in …
Maintenance Therapies in Metastatic Colorectal Cancer - Targeted …